查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451029

2024-2032 年按产品和服务、技术、应用、最终用户和地区分類的细胞分析市场报告

Cell-based Assay Market Report by Product and Services, Technology, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球细胞检测市场规模达到 225 亿美元。展望未来， IMARC Group预计，到 2032 年，市场规模将达到 429 亿美元，2024-2032 年复合年增长率 (CAGR) 为 7.2%。对解决各种疾病的新疗法的需求不断增长、对个性化药物的日益关注以及提高药物筛选准确性的细胞培养技术创新是推动市场的一些主要因素。

基于细胞的测定，也称为细胞测定，是一种实验室技术，用于各种科学和医学领域，用于评估细胞对特定物质或条件的生物活性。它包括在受控环境中培养活细胞并将其暴露于各种刺激，例如药物、化合物或环境因素。由于它使研究人员能够透过监测细胞行为的变化（例如细胞活力或特定生物标记的表达）来深入了解被测物质对细胞功能的影响，因此全球范围内对基于细胞的检测的需求正在不断增加。

目前，基于细胞的检测方法越来越多地用于药物发现、毒理学研究、疾病建模和了解细胞机制，正在支持市场的成长。除此之外，评估药物化合物的潜在功效和安全性的需求日益增长，正在加强市场的成长。此外，对基于细胞的检测的需求不断增长，因为它们使研究人员能够在开发过程的早期识别潜在的不利影响并评估化学品的毒性，正在对市场产生积极影响。除此之外，世界各地癌症、糖尿病和自体免疫疾病等多种慢性疾病的发生率不断上升，为产业投资者提供了利润丰厚的成长机会。此外，评估化学物质和污染物对植物和水生系统影响的需求不断增长，也推动了市场的成长。

基于细胞的检测市场趋势/驱动因素：

对解决各种疾病的新疗法的需求不断增长

对药物发现和开发的日益关注，以及全球个人对解决各种慢性疾病的新疗法的需求不断增加，正在促进市场的成长。此外，基于细胞的检测使研究人员能够快速有效地筛选和评估大量潜在的候选药物。透过将细胞暴露于不同的化合物，科学家可以评估它们对细胞行为的影响，包括它们的功效和安全性。除此之外，人们越来越关注精准医学，因此需要深入了解药物如何与特定细胞途径相互作用。此外，这些测定提供了一个根据个别患者情况定製药物治疗的平台。

越来越重视个人化药物

大众对个人化药物的日益关注正在支持市场的成长。与此一致，医疗机构正迅速专注于客製化治疗解决方案，以适应个别患者的遗传、分子和细胞特征。除此之外，基于细胞的检测使研究人员能够评估患者来源的细胞对各种药物和治疗的反应，并能够确定最有效的疗法，同时最大限度地减少潜在的副作用。此外，个人化医疗不仅可以改善治疗结果，还可以透过避免无效治疗来降低医疗成本。因此，基于细胞的检测在临床和研究环境中的采用有所增加，因为它们为根据患者的特定需求量身定制医疗干预措施提供了强大的工具。

细胞培养技术的创新

细胞培养技术的进步正在增强基于细胞的检测的能力。 3D 培养和类器官使研究人员能够研究更接近人体的细胞行为，以提高药物筛选和毒性测试的准确性，这提供了积极的市场前景。此外，微流体和晶片实验室技术能够开发小型化和自动化的基于细胞的检测，有助于提高药物发现的通量和效率。据此，将这些先进的细胞培养技术整合到基于细胞的检测中有助于增强其相关性和适用性，这使它们成为了解疾病机制和更精确地评估候选药物的合适工具。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球细胞检测市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：按产品和服务
  • 市场区隔：按技术
  • 市场区隔：按应用
  • 市场区隔：按最终用户
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第 6 章：市场区隔：依产品与服务

  • 耗材
    • 试剂和介质
      • 市场走向
      • 市场预测
    • 细胞和细胞系
      • 市场走向
      • 市场预测
    • 探针和标籤
      • 市场走向
      • 市场预测
  • 仪器
    • 微孔板
      • 市场走向
      • 市场预测
    • 酶标仪
      • 市场走向
      • 市场预测
    • 高通量筛选
      • 市场走向
      • 市场预测
    • 液体处理系统
      • 市场走向
      • 市场预测
  • 服务
    • 市场走向
    • 市场预测
  • 软体
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 自动化处理
    • 市场走向
    • 市场预测
  • 流式细胞仪
    • 市场走向
    • 市场预测
  • 无标记检测
    • 市场走向
    • 市场预测
  • 高通量筛选
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 药物发现
    • 市场走向
    • 市场预测
  • 基础研究
    • 市场走向
    • 市场预测
  • ADME研究
    • 市场走向
    • 市场预测
  • 预测毒理学
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 学术和政府机构
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 11 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Becton, Dickinson and Company
    • Global Life Sciences Solutions USA LLC (DBA Cytiva)
    • Thermo Fisher Scientific Inc.
    • Merck Group
    • PerkinElmer Inc.
    • Charles River Laboratories Inc.
    • Lonza Group Ltd.
    • Cell Signaling Technology
    • Promega Corporation
    • Cell Biolabs Inc.
    • Eurofins DiscoverX Corporation
    • Bio-Rad Laboratories Inc.
    • Corning Inc.
    • F. Hoffmann-La Roche AG (Roche Holding AG)
Product Code: SR112024A1079

The global cell-based assay market size reached US$ 22.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032. The growing demand for novel therapies to address various diseases, rising focus on personalized medicines, and innovations in cell culture technologies to improve the accuracy of drug screening are some of the major factors propelling the market.

A cell-based assay, also known as a cellular assay, is a laboratory technique that is used in various scientific and medical fields to assess the biological activity of cells in response to specific substances or conditions. It comprises culturing living cells in controlled environments and exposing them to various stimuli, such as drugs, compounds, or environmental factors. As it allows researchers to gain critical insights into the effects of the tested substances on cellular function by monitoring changes in cell behavior, such as cell viability or the expression of specific biomarkers, the demand for cell-based assay is increasing worldwide.

At present, the rising adoption of cell-based assays for drug discovery, toxicology studies, disease modeling, and understanding cellular mechanisms is supporting the growth of the market. Besides this, the increasing need to evaluate the potential efficacy and safety of pharmaceutical compounds is strengthening the growth of the market. Additionally, the growing demand for cell-based assays, as they enable researchers to identify potential adverse effects early in the development process and assess the toxicity of chemicals, is positively influencing the market. Apart from this, increasing incidences of numerous chronic diseases, such as cancer, diabetes, and autoimmune disorders, among individuals around the world are offering lucrative growth opportunities to industry investors. Furthermore, the rising need to assess the impact of chemicals and pollutants on plant and aquatic systems is bolstering the growth of the market.

Cell-Based Assay Market Trends/Drivers:

Rising demand for novel therapies to address various diseases

The rising focus on drug discovery and development, along with the increasing demand for novel therapies to address various chronic diseases among individuals across the globe, is contributing to the growth of the market. In addition, cell-based assays enable researchers to screen and evaluate a vast number of potential drug candidates quickly and efficiently. By exposing cells to different compounds, scientists can assess their impact on cellular behavior, including their efficacy and safety profiles. Apart from this, there is an increase in the focus on precision medicine that necessitates a deep understanding of how drugs interact with specific cellular pathways. Moreover, these assays provide a platform for tailoring drug treatments to individual patient profiles.

Increasing focus on personalized medicines

The rising focus on personalized medicines among the masses is supporting the growth of the market. In line with this, healthcare facilities are rapidly focusing on treatment solutions that are customized to suit the genetic, molecular, and cellular characteristics of individual patients. Besides this, cell-based assays allow researchers to evaluate the response of patient-derived cells to various drugs and treatments and enable the identification of the most effective therapies while minimizing potential side effects. In addition, personalized medicine not only improves treatment outcomes but also reduces healthcare costs by avoiding ineffective treatments. As a result, there is an increase in the adoption of cell-based assays in both clinical and research settings, as they provide a powerful tool for tailoring medical interventions to the specific needs of patients.

Innovations in cell culture technologies

Advancements in cell culture techniques are enhancing the capabilities of cell-based assays. 3D cultures and organoids allow researchers to study cell behavior closer to the human body to improve the accuracy of drug screening and toxicity testing, which is offering a positive market outlook. Additionally, microfluidics and lab-on-a-chip technologies enable the development of miniaturized and automated cell-based assays that assist in increasing throughput and efficiency in drug discovery. In line with this, the integration of these advanced cell culture technologies into cell-based assays aids in enhancing their relevance and applicability, which makes them suitable tools for understanding disease mechanisms and evaluating drug candidates with greater precision.

Cell-Based Assay Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell-based assay market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and services, technology, application and end-user.

Breakup by Product and Services:

Consumables

Reagents and Media

Cells and Cell Lines

Probes and Labels

Instruments

Microplates

Microplate Readers

High Throughput Screening

Liquid Handling Systems

Services

Software

Consumables represent the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product and services. This includes consumables (reagents and media, cells and cell lines, and probes and labels), instruments (microplates, microplate readers, high throughput screening, and liquid handling systems), services, and software. According to the report, consumables represented the largest segment. Consumables refer to a wide range of disposable laboratory materials and reagents that are essential for conducting cell-based experiments and assays. They include cell culture media, reagents for cell proliferation and viability assays, cell culture plates, assay kits, antibodies, and other materials used on a one-time or limited-use basis. In addition, consumables ensure the proper growth and maintenance of cells in culture and provide the necessary tools for detecting cellular responses that enable the execution of various assays efficiently. They play a crucial role in ensuring the accuracy, reproducibility, and reliability of results in cell-based experiments.

Breakup by Technology:

Automated Handling

Flow Cytometry

Label-Free Detection

High-Throughput Screening

Others

High-throughput screening accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes automated handling, flow cytometry, label-free detection, high-throughput screening, and others. According to the report, high-throughput screening represented the largest segment. High-throughput screening (HTS) is a technology-driven approach used in drug discovery, which allows researchers to quickly test thousands to millions of compounds for their biological activity. HTS systems are designed to automate the screening process and enable the rapid evaluation of potential drug candidates. It involves the use of robotic systems and specialized equipment to perform assays on a large scale. It typically utilizes microplates with multiple wells, where each well contains cells or biochemical components for testing. The technology allows for the identification of compounds that exhibit desired biological effects, such as binding to a specific target or modulating a cellular response.

Breakup by Application:

Drug Discovery

Basic Research

ADME Studies

Predictive Toxicology

Others

Drug discovery dominates the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes drug discovery, basic research, ADME studies, predictive toxicology, and others. According to the report, drug discovery represented the largest segment. Drug discovery refers to the techniques and technologies used to administer therapeutic substances, such as drugs or biologics, to the targeted cells or tissues within the body. These assays play a critical role in the development and optimization of drug delivery systems by providing valuable insights into their efficacy and safety. In addition, they are used to assess targeted delivery, screen for cellular uptake, evaluate drug release kinetics, and assay drug toxicity. Researchers employ cell-based models to evaluate the ability of drug delivery systems, such as nanoparticles or liposomes, to specifically target and interact with particular cell types or tissues.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutions

Contract Research Organizations

Others

Pharmaceutical and biotechnology companies hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment. Pharmaceutical and biotechnology employ these assays to identify and validate potential drug candidates, assess their efficacy, and evaluate safety profiles. They enable high-throughput screening of compound libraries that enhance the drug development pipeline. In line with this, these companies utilize these assays to ensure the safety of drug candidates. These assays assist in assessing the cytotoxicity and potential adverse effects of compounds that benefit companies complying with regulatory requirements. Moreover, these assays are employed for quality control purposes to ensure the consistency and reliability of pharmaceutical and biotechnological products.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest cell-based assay market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing demand for advanced assay technologies and consumables. In addition, the rising development of novel cell-based assay techniques is bolstering the growth of the market in the region. Apart from this, the growing focus on drug safety is positively influencing the market. In line with this, stringent regulatory standards are propelling the growth of the market in the North America region.

Competitive Landscape:

Major players are developing innovative assay technologies, such as novel reagents, assay kits, and platforms. This involves creating more physiologically relevant cell models to improve assay sensitivity and enhance automation and data analysis capabilities. In line with this, companies are expanding their product portfolios to cater to a wide range of applications. This includes offering assays tailored for specific targets, pathways, or disease models, and developing specialized kits for toxicity testing and drug screening. Apart from this, key manufacturers are providing customized assay development services and are working closely with clients to tailor assays to their specific research needs, which is offering a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Becton, Dickinson and Company

Global Life Sciences Solutions USA LLC (DBA Cytiva)

Thermo Fisher Scientific Inc.

Merck Group

PerkinElmer Inc.

Charles River Laboratories Inc.

Lonza Group Ltd.

Cell Signaling Technology

Promega Corporation

Cell Biolabs Inc.

Eurofins DiscoverX Corporation

Bio-Rad Laboratories Inc.

Corning Inc.

F. Hoffmann-La Roche AG (Roche Holding AG)

Recent Developments:

In December 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. to provide a complete suite of services across the clinical development spectrum, comprising scientific discovery, safety, efficacy and healthcare outcome assessment, handling trial logistics, and the development and production of the therapeutics.

In March 2022, Promega Corporation and FUJIFILM Cellular Dynamics, Inc. announced a strategic collaboration to advance novel assay development for drug discovery. The collaboration will merge bioluminescent reporter technology used to study cellular signaling and transcriptional activity in iPSCs.

In 2022, BD (Becton, Dickinson and Company) introduced the BD Rhapsody(TM) TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system and provide a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.

Key Questions Answered in This Report

  • 1. What was the size of the global cell-based assay market in 2023?
  • 2. What is the expected growth rate of the global cell-based assay market during 2024-2032?
  • 3. What are the key factors driving the global cell-based assay market?
  • 4. What has been the impact of COVID-19 on the global cell-based assay market?
  • 5. What is the breakup of the global cell-based assay market based on the product and services?
  • 6. What is the breakup of the global cell-based assay market based on the technology?
  • 7. What is the breakup of the global cell-based assay market based on the application?
  • 8. What is the breakup of the global cell-based assay market based on the end-user?
  • 9. What are the key regions in the global cell-based assay market?
  • 10. Who are the key players/companies in the global cell-based assay market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell-Based Assay Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Services
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product and Services

  • 6.1 Consumables
    • 6.1.1 Reagents and Media
      • 6.1.1.1 Market Trends
      • 6.1.1.2 Market Forecast
    • 6.1.2 Cells and Cell Lines
      • 6.1.2.1 Market Trends
      • 6.1.2.2 Market Forecast
    • 6.1.3 Probes and Labels
      • 6.1.3.1 Market Trends
      • 6.1.3.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Microplates
      • 6.2.1.1 Market Trends
      • 6.2.1.2 Market Forecast
    • 6.2.2 Microplate Readers
      • 6.2.2.1 Market Trends
      • 6.2.2.2 Market Forecast
    • 6.2.3 High Throughput Screening
      • 6.2.3.1 Market Trends
      • 6.2.3.2 Market Forecast
    • 6.2.4 Liquid Handling Systems
      • 6.2.4.1 Market Trends
      • 6.2.4.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Automated Handling
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Label-Free Detection
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 High-Throughput Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Basic Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 ADME Studies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Predictive Toxicology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Government Institutions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Becton, Dickinson and Company
    • 11.3.2 Global Life Sciences Solutions USA LLC (DBA Cytiva)
    • 11.3.3 Thermo Fisher Scientific Inc.
    • 11.3.4 Merck Group
    • 11.3.5 PerkinElmer Inc.
    • 11.3.6 Charles River Laboratories Inc.
    • 11.3.7 Lonza Group Ltd.
    • 11.3.8 Cell Signaling Technology
    • 11.3.9 Promega Corporation
    • 11.3.10 Cell Biolabs Inc.
    • 11.3.11 Eurofins DiscoverX Corporation
    • 11.3.12 Bio-Rad Laboratories Inc.
    • 11.3.13 Corning Inc.
    • 11.3.14 F. Hoffmann-La Roche AG (Roche Holding AG)

List of Figures

  • Figure 1: Global: Cell-Based Assay Market: Major Drivers and Challenges
  • Figure 2: Global: Cell-Based Assay Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cell-Based Assay Market: Breakup by Product and Services (in %), 2023
  • Figure 4: Global: Cell-Based Assay Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Cell-Based Assay Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cell-Based Assay Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Cell-Based Assay Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cell-Based Assay Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Cell-Based Assay Industry: SWOT Analysis
  • Figure 10: Global: Cell-Based Assay Industry: Value Chain Analysis
  • Figure 11: Global: Cell-Based Assay Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Cell-Based Assay (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cell-Based Assay (Consumables- Reagents and Media) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cell-Based Assay (Consumables- Reagents and Media) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cell-Based Assay (Consumables- Probes and Labels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cell-Based Assay (Consumables- Probes and Labels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cell-Based Assay (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cell-Based Assay (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cell-Based Assay (Instruments-Microplates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cell-Based Assay (Instruments-Microplates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cell-Based Assay (Instruments-Microplate Readers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cell-Based Assay (Instruments- Microplate Readers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cell-Based Assay (Instruments-High Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cell-Based Assay (Instruments- High Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cell-Based Assay (Instruments- Liquid Handling Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cell-Based Assay (Instruments-Liquid Handling Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cell-Based Assay (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Cell-Based Assay (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Cell-Based Assay (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Cell-Based Assay (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Cell-Based Assay (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Cell-Based Assay (Automated Handling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Cell-Based Assay (Automated Handling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Cell-Based Assay (Flow Cytometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Cell-Based Assay (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Cell-Based Assay (Label-Free Detection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Cell-Based Assay (Label-Free Detection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Cell-Based Assay (High-Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Cell-Based Assay (High-Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Cell-Based Assay (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Cell-Based Assay (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Cell-Based Assay (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Cell-Based Assay (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Cell-Based Assay (Basic Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Cell-Based Assay (Basic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Cell-Based Assay (ADME Studies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Cell-Based Assay (ADME Studies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Cell-Based Assay (Predictive Toxicology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Cell-Based Assay (Predictive Toxicology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Cell-Based Assay (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Cell-Based Assay (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Cell-Based Assay (Academic and Government Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Cell-Based Assay (Academic and Government Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Cell-Based Assay (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Cell-Based Assay (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Cell-Based Assay (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Cell-Based Assay (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: North America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: North America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Asia Pacific: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Asia Pacific: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Cell-Based Assay Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cell-Based Assay Market Forecast: Breakup by Product and Services (in Million US$), 2024-2032
  • Table 3: Global: Cell-Based Assay Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Cell-Based Assay Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Cell-Based Assay Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Cell-Based Assay Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cell-Based Assay Market: Competitive Structure
  • Table 8: Global: Cell-Based Assay Market: Key Players